tiprankstipranks
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29d ago
Kura Oncology reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
29d ago
Kura Oncology reports Q1 EPS (59c), consensus (55c)
PremiumThe Fly
Kura Oncology reports Q1 EPS (59c), consensus (55c)
30d ago
Kura Oncology to Participate in Stifel Targeted Oncology Forum
PremiumPress ReleasesKura Oncology to Participate in Stifel Targeted Oncology Forum
2M ago
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2M ago
Kura Oncology reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
2M ago
Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress ReleasesKura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
3M ago
Kura Oncology doses first patient in KOMET-008 trial of ziftomenib
PremiumThe Fly
Kura Oncology doses first patient in KOMET-008 trial of ziftomenib
3M ago
Kura Oncology Doses First Patient in KOMET-008 Trial of Ziftomenib in Combination with Standards of Care, Including FLT3 Inhibitor, in Acute Myeloid Leukemia
PremiumPress Releases
Kura Oncology Doses First Patient in KOMET-008 Trial of Ziftomenib in Combination with Standards of Care, Including FLT3 Inhibitor, in Acute Myeloid Leukemia
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100